Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eton Pharmaceutcials Inc (NQ: ETON )

3.140 -0.050 (-1.57%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 94,860
Open 3.190
Bid (Size) 2.990 (2)
Ask (Size) 3.640 (1)
Prev. Close 3.190
Today's Range 3.030 - 3.220
52wk Range 2.420 - 5.810
Shares Outstanding 25,688,062
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
From Eton Pharmaceuticals
Via GlobeNewswire

Performance

YTD
-31.59%
-31.59%
1 Month
-9.77%
-9.77%
3 Month
-24.15%
-24.15%
6 Month
-22.47%
-22.47%
1 Year
-10.03%
-10.03%

More News

Read More
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Recap: Eton Pharmaceuticals Q4 Earnings
Via Benzinga
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals Earnings Preview
Via Benzinga
Is NASDAQ:ETON suited for growth investing?
Via Chartmill
Earnings Scheduled For March 14, 2024
Via Benzinga
Why the growth investor may take a look at NASDAQ:ETON.
Via Chartmill
Evaluating NASDAQ:ETON for Growth Investment Opportunities.
Via Chartmill
Eton Pharmaceuticals: Q3 Earnings Insights
Via Benzinga
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
From Eton Pharmaceuticals
Via GlobeNewswire
Gilead Sciences Tops Q3 Earnings And Revenue Estimates
Via Talk Markets
Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
From Eton Pharmaceuticals
Via GlobeNewswire
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Consolidated Water, Spectrum Brands, Arco Platform, Semler Scientific And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
FSR Stock Alert: What to Know About the New Fisker Ronin EV
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Is Cano Health (CANO) Stock Down 48% Today?
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.